Abstract:Background: Organophosphate esters (OPEs) are increasingly used as flame retardants and plasticizers in various products. In vivo and in vitro studies suggest that OPEs can affect metabolic health but the human evidence is lacking. Objectives: We analyzed data from the U.S. National Health and Nutrition Examination Survey, 2011-2014, to examine the associations between urinary OPE metabolites and metabolic syndrome (MetS) and its components in adults. Methods: We included a total of 1157 adults aged ≥20 years who had information on urinary OPE metabolites, components of MetS and essential covariates in the current analyses. MetS was composed of hyperglycemia, hypertension, hypertriglyceridemia, low high-density cholesterol, and central obesity. Binary logistic regression and weighted quantile sum (WQS) regression were used to assess the associations of individual OPE metabolites and OPEs mixture with MetS and its components. All analyses were conducted in men and women separately. Potential effect modification by age, serum total testosterone (TT) level and menopause status were also examined via stratified analyses as well as by testing the significance of the interaction term with exposure. Results: After adjusting for confounders, bis(2-chloroethyl) phosphate (BCEP) and bis(1,3-dichloro-2-propyl) phosphate (BDCPP) were positively associated with MetS in a dose-dependent manner (P-trend = 0.02 and 0.02 for BCEP and BDCPP, respectively) in all men. Meanwhile, increasing quartiles of DPHP was positively associated with hyperglycemia (P-trend = 0.03), but DBUP was inversely associated with central obesity (P-trend = 0.02). WQS analyses in all men found that OPEs mixture (OPEs index) was positively associated with MetS [odds ratio (OR) for OPEs index: 1.65; 95%CI :1.21, 2.24], hyperglycemia (OR:1.47; 95%CI:1.09,2.00), and central obesity (OR:1.36; 95%CI:1.01,1.83). Although there was no significant interaction between exposure and effect modifiers, stratified analyses in men suggested that significant associations were mainly limited to those aged < 60 years or those with TT < 437 ng/dL (the median level in men). By contrast, the associations with MetS and its components were sparse and inconsistent in women except for the positive association between OPEs index and central obesity. Conclusions: In this cross-sectional study, exposure to OPEs was positively associated with elevated odds of MetS and individual components in men, especially among those aged <60 years or those with relatively low TT level. But the associations were less apparent in women except for the consistent positive association of OPEs mixture with central obesity. Nevertheless, these results need to be interpreted with caution and should be confirmed in future studies, ideally with multiple urine samples collected prospectively to improve the exposure measurement of OPEs.

The Relationship of Organophosphate Flame Retardants with Hyperuricemia and Gout Via the Inflammatory Response: an Integrated Approach.

Oxidative Stress Mediates the Association of Organophosphate Flame Retardants with Metabolic Obesity in U.S. Adults: a Combined Epidemiologic and Bioinformatic Study

Exposure to OPFRs Is Associated with Obesity and Dysregulated Serum Lipid Profiles: Data from 2017–2018 NHANES

Association between organophosphate flame retardant exposure and lipid metabolism: data from the 2013–2014 National Health and Nutrition Examination Survey

Organophosphorus Flame Retardants and Their Metabolites in Paired Human Blood and Urine

Relationship Between Phthalates Exposures and Hyperuricemia in U.S. General Population, a Multi-Cycle Study of NHANES 2007–2016

Potential Glucocorticoid and Mineralocorticoid Effects of Nine Organophosphate Flame Retardants

Association analysis between organophosphorus flame retardants exposure and the risk of depression: Data from NHANES 2017–2018

Association Between Exposure to a Mixture of Organochlorine Pesticides and Hyperuricemia in U.S. Adults: A Comparison of Four Statistical Models

Assessing the health risk of hyperuricemia in participants with persistent organic pollutants exposure - a systematic review and meta-analysis

Biomonitoring urinary organophosphorus flame retardant metabolites by liquid–liquid extraction and ultra-high performance liquid chromatography-tandem mass spectrometry and their association with oxidative stress

Association between organophosphorus insecticides exposure and osteoarthritis in patients with arteriosclerotic cardiovascular disease

Associations of Exposure to Phthalate with Serum Uric Acid and Hyperuricemia Risk, and the Mediating Role of Systemic Immune Inflammation

Association between exposure to perfluoroalkyl substances and uric acid in Chinese adults

Association of Co-Exposure to Organophosphate Esters and Per- and Polyfluoroalkyl Substances and Mixture with Cardiovascular-Kidney-liver-metabolic Biomarkers among Chinese Adults

New findings on the risk of hypertension from organophosphorus exposure under different glycemic statuses: The key role of lipids?

Urinary Concentrations of Organophosphate Flame-Retardant Metabolites in the US Population

Relationship of single and co-exposure of per-and polyfluoroalkyl substances and their alternatives with uric acid: A community-based study in China

Exposure to Organophosphate esters and metabolic syndrome in adults

1H NMR-based Metabolomic Analysis of Nine Organophosphate Flame Retardants Metabolic Disturbance in Hep G2 Cell Line.

Association between urinary organophosphate ester metabolite exposure and thyroid disease risk among US adults: National Health and Nutrition Examination Survey 2011-2014